The model yielded nine drugs considered likely to provide those therapeutic benefits, three of which are currently in use – meaning the analysis identified six candidates for drug repurposing
Quite interesting! Was wondering if/how this novel approach could be translated into a business. Maybe it earns referral $ if the drug candidate can be successfully repurposed and also does it mean that the IP is protected for another 20 years?